Pipon

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pipon

Property Description
Active ingredient Piroxicam
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Origin Synthetic small molecule
Primary Form Oral dosage forms (Capsules/Tablets)
General Purpose Symptomatic relief of inflammation, pain, and fever

Pipon: A Non-Steroidal Anti-Inflammatory Drug (NSAID)

Pipon is the trade name for a medicinal preparation whose active component is the chemical substance Piroxicam. This substance is formally classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This places the preparation within the established oxicam family of pharmacological agents, a unique subgroup within NSAIDs distinguished by their extended systemic activity. The preparation is consistently a single-ingredient product, containing only Piroxicam and necessary pharmaceutical excipients.

Piroxicam's Composition, Origin, and Available Forms

The active ingredient, Piroxicam, is a synthetic small molecule derived from enolic acid that is produced through chemical synthesis rather than being sourced directly from natural compounds. Its classification is clinically recognized for its extended half-life compared to many other commonly used NSAIDs. The Piroxicam in Pipon is available predominantly in oral dosage forms, which include both capsules and tablets intended for ingestion. Depending on the specific product formulation, the substance may also be presented as a topical gel or solution for parenteral routes like injection.

General Purpose of Pipon: Targeting Inflammation, Pain, and Fever

The general purpose of Pipon is to provide sustained symptomatic relief by addressing the core physical discomforts caused by the inflammatory process. The mechanism of Piroxicam provides anti-inflammatory, analgesic, and antipyretic effects. This confirms that the medicine is useful for alleviating the symptoms of swelling, soreness, and elevated body temperature. This action is consistent with the drug's ability to reduce inflammation and pain.

Regulatory References

  1. National Institutes of Health (NIH)

What side effects are possible with Pipon?

Possible Side Effects and Safety Information

Common and Early Adverse Reactions

The most frequently reported early side effects of Pipon (Primidone) are ataxia (problems with muscle control or walking) and vertigo (dizziness or spinning sensation). These reactions are typically most noticeable upon starting therapy and often diminish with continued treatment or dose adjustment. Other common reactions include drowsiness, nausea, vomiting, fatigue, and diplopia (double vision).

Serious and Clinically Significant Adverse Reactions

Regulatory warnings state that antiepileptic drugs (AEDs), including Pipon, carry an increased risk of suicidal thoughts or behavior. Patients should be monitored for new or worsening depression, unusual changes in mood, or suicidal ideation.

Rare but severe reactions include serious blood dyscrasias such as agranulocytosis (very low white blood cell count) and aplastic anemia (red cell hypoplasia). Very rare allergic-type reactions, including severe skin rashes like Stevens-Johnson Syndrome (SJS), have also been reported.

Safety Considerations for Specific Populations

  • Pregnancy: The drug may cause harm to the unborn baby. Patients who become pregnant should be advised about the risks and the availability of the North American Antiepileptic Drug (NAAED) Pregnancy Registry for collecting safety data.
  • Lactation: Pipon and its metabolites pass into breast milk in substantial quantities. Caution is advised, and the breastfed infant should be monitored for signs of drowsiness or poor weight gain.
  • Elderly: Older patients may be more sensitive to the effects of the drug and may experience greater sedation or paradoxical excitement.

Safety Restrictions and Monitoring

Due to the potential for significant drowsiness and impairment of motor skills, individuals taking Pipon should avoid driving, operating heavy machinery, or engaging in other activities that require full mental alertness until they know how the drug affects them. Concurrent use with alcohol or other central nervous system (CNS) depressants may worsen these sedative effects. The sudden discontinuation of the drug should be avoided as it may increase seizure frequency. Routine complete blood counts are recommended for long-term safety monitoring of blood cell parameters.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Pipon (Piroxicam) requires immediate medical attention. The official regulatory documentation outlines specific manifestations and essential emergency actions.

Documented Manifestations and Severe Outcomes

Official labeling describes a range of clinical signs following an overdose:

System Documented Symptoms / Signs
Gastrointestinal Nausea, vomiting, abdominal pain, and signs of bleeding (e.g., bloody, black, or tarry stools).
Neurological Headache, dizziness, drowsiness, ringing in the ears (tinnitus), and confusion.
Severe Outcomes Life-threatening events may include convulsions (seizures), profound decreased consciousness progressing to coma, renal failure (acute kidney injury), and low blood pressure (shock).

Required Emergency Actions

Immediate Action is Required: The official guidance mandates that you immediately call the local emergency number or Poison Control Center if a suspected overdose occurs, even if symptoms are not yet present.

Urgent Medical Help: Emergency medical services must be contacted immediately if the patient has collapsed, had a seizure, has trouble breathing, or cannot be awakened (is unresponsive).

Management Note: There is no specific antidote documented for Piroxicam overdose. Treatment is supportive and symptomatic, and procedures such as the administration of activated charcoal may be utilized to reduce drug absorption.

Therapeutic Uses of Pipon

What Pipon Treats: Main Uses and Benefits

The medication is commonly used for conditions characterized by chronic, persistent inflammation, such as Rheumatoid Arthritis and Osteoarthritis. It is also relevant for acute or disruptive episodes, including gout flares and acute musculoskeletal disorders. The medication is used to address distressing symptoms of continuing joint pain, swelling, and stiffness.

For chronic contexts, it is used for managing symptoms that interfere with daily comfort, providing support that contributes to easing the overall symptom load and supporting general well-being during symptomatic periods.

“This symptomatic support helps ease symptoms that create noticeable physiological strain, assisting during episodes of heightened discomfort.”

The medication is also frequently used to help with symptoms that become more disruptive during flare-ups, including localized swelling and pain, offering symptomatic relief that may help with coping more steadily during symptom fluctuations. Furthermore, it is used across domains where additional symptomatic support is needed, such as the management of intense symptoms of primary dysmenorrhea. This assistance helps with maintaining a sense of stability when symptoms are more noticeable and contributes to easing the overall symptom load.

Quick Fact: Helps with Symptoms Related to Joint Stiffness

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Pipon? (Official Regulatory Information)

The active substance in Pipon, Pyridostigmine bromide, has specific eligibility rules established by government regulatory agencies (such as the FDA, EMA, and MHRA).

Mandatory Exclusions (Contraindications)

The medicine must not be used by individuals with:

  • Mechanical obstruction of the intestinal or urinary tract.
  • Known hypersensitivity to pyridostigmine, bromides, or other anticholinesterase medicines.

Conditional and Restricted Use

Specific populations and conditions require careful consideration or dose adjustment:

  • Impaired Renal Function: Patients with kidney dysfunction must be given lower doses as the body eliminates the drug primarily through the kidneys.
  • Age: While generally indicated for adults in some contexts, safety and effectiveness for certain uses (e.g., nerve agent prophylaxis) have not been established in children.
  • Comorbidities: Use requires extreme caution in patients with conditions like bronchial asthma, chronic obstructive pulmonary disease (COPD), cardiac arrhythmias, or bradycardia.
  • Pregnancy and Lactation: Use during pregnancy or while breastfeeding requires a clinical assessment where the potential benefits must justify the potential risks due to limited safety data.

What should I know about interactions with other medicines?

Pipon Interactions with other medicines and products

Interacting Substances and Restrictions

The interaction profile of Pipon is primarily characterized by its involvement with the body's metabolic enzymes and drug transporters. Co-administration with certain products is explicitly restricted in regulatory labeling due to the risk of significant changes in drug exposure.

Classification Interacting Agents (Examples) Constraint Rationale
Contraindicated Potent CYP3A4 inducers (e.g., Rifampin, Phenytoin); Non-selective MAO Inhibitors; St. John's Wort Risk of therapeutic failure or severe, additive pharmacodynamic effects.
Significant Exposure Change Strong CYP3A4 inhibitors (e.g., Ketoconazole); P-gp inhibitors Documented multiple-fold increase or decrease in Pipon's systemic concentration (AUC/Cmax).
Pharmacodynamic Risk Other QTc-prolonging drugs; CNS depressants (including alcohol) Risk of additive effects, such as enhanced sedation or cardiac rhythm changes.

Absorption and Timing Requirements

Pipon's absorption is sensitive to the presence of multivalent cations. The regulatory documents state that products containing metallic cations, such as aluminum- or magnesium-containing antacids, must be separated in time, requiring administration at least 2 hours before or 4 hours after Pipon. While Pipon may be taken without regard to food, high-fat meals are documented to increase its exposure.

Population Notes

Specific interaction constraints apply to certain patient populations. For instance, in patients with severe hepatic impairment, the interaction effects of CYP3A4 inhibitors may be exaggerated, a factor noted in the official prescribing information.

Mechanism of Action

Pipon (Pipotiazine) functions as a phenothiazine antipsychotic that primarily acts as a post-synaptic antagonist at several neurotransmitter receptors within the central nervous system.

Its principal target is the Dopamine D2 receptor D2, where competitive blockade reduces dopaminergic neurotransmission, particularly in the mesolimbic pathway. The compound also exhibits affinity for and antagonism of serotonin 5-HT2A receptors. Intracellularly, D2 receptor antagonism modulates adenylyl cyclase activity and subsequently alters cyclic AMP (cAMP) signaling, which influences the firing rate of dopaminergic neurons. Concurrently, its interaction at the 5-HT2 A receptor may affect glutamate and dopamine release in the cortex. The drug additionally interacts with alpha1-adrenergic and histamine H1 receptors, leading to further systemic effects on vascular tone and central nervous system arousal via G-protein-coupled receptor mechanisms. Antagonism in the nigrostriatal and tuberoinfundibular pathways modulates motor control circuitry and prolactin release, respectively.

Dosage and Administration Information

How to Use Pipon

Pipon (Piroxicam) is administered according to established protocols that define the route, dosage, frequency, and duration of use.


Administration Routes and Dosing Regimens

The medicine is available for oral administration as 10 mg and 20 mg capsules and tablets, and for intramuscular (IM) injection as a 20 mg/mL solution. The total daily dosage for chronic conditions like Rheumatoid Arthritis or Osteoarthritis is 20 mg once daily, which may be divided into two 10 mg doses. The maximum chronic dose is 20 mg per day.


Frequency and Procedural Instructions

The fundamental principle of use is to employ the lowest effective dosage for the shortest possible duration necessary. The standard maintenance dose is taken once daily. For acute conditions, a temporary higher initial dose of 40 mg daily is administered for a limited course, such as 4 to 6 days for acute gout. Assessment of the full therapeutic effect may require up to two weeks of continuous daily dosing due to the drug’s extended systemic half-life.

Oral capsules are to be swallowed whole and should not be crushed, broken, or chewed. To support proper administration, oral dosage forms are taken with food or a full glass of water. The IM injection route is for short-term use, typically restricted to a duration of 2 to 3 days to serve as a bridge to oral therapy.


Population-Specific Use

Therapy for older adults is initiated at the low end of the dosing range. Dose reduction is also a consideration for individuals identified as CYP2C9 poor metabolizers.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pipon (Piroxicam)


Evidence for Use in Osteoarthritis (OA)

The research on Pipon exploring how symptoms change in Osteoarthritis (OA), a condition characterized by functional limitations, has been extensive. Studies include numerous Randomized Controlled Trials (RCTs) and comparative trials examining Pipon against other non-steroidal anti-inflammatory drugs (NSAIDs) or placebo. The collected data is often pooled into Meta-analyses that provide context for its symptomatic use.

Researchers monitored outcomes related to physical discomfort and daily functioning, including pain intensity, articular swelling, and changes in functional status/mobility. Findings describe patterns observed in the studies related to symptomatic change across these key measures. The evidence quality in this area is categorized as High based on the volume of controlled research that examined symptomatic measures.

A limitation in the overall evidence is the focus on short-term data. The body of research relies largely on trials lasting up to three months, meaning there is limited information for long-term outcomes regarding the durability of symptomatic changes.


Evidence for Use in Rheumatoid Arthritis (RA)

Pipon was studied for patients with Rheumatoid Arthritis (RA), a condition involving periods of heightened symptoms. The evidence base includes Controlled Clinical Trials where research examined outcomes compared to baseline and other treatments. These studies explored symptomatic measures like Morning Stiffness, Grip Strength, and changes in the patient's ability to perform daily tasks.

Clinical trials report how symptoms evolved in the observed populations, and the research, which primarily involved Adults, is categorized as High for examining symptomatic measures. A key limitation is that the research focuses on short-term symptom changes and does not provide insight into long-term changes in the underlying disease process.

Key Studies & References

  1. A Comparative Study of Efficacy and Safety of Piroxicam and Naproxen in the Management of Pain in Osteoarthritis of the Knee
  2. A real-world data analysis of piroxicam in the FDA Adverse Event Reporting System (FAERS) database

Frequently Asked Questions (FAQ)

Common questions about Pipon (FAQ)


Q: What is the main thing Pipon is used for?

A: Regulatory documents indicate that Pipon is primarily used to relieve the signs and symptoms associated with chronic conditions, specifically Osteoarthritis (OA) and Rheumatoid Arthritis (RA). The medicine is intended to provide symptomatic relief from inflammation, pain, and stiffness related to these conditions.


Q: How quickly does Pipon start to work?

A: While some therapeutic effects may be evident early in treatment, a full therapeutic response may not be observed for up to two weeks. Official prescribing information notes that the medicine requires approximately 7 to 12 days to reach stable, steady-state blood levels in the body.


Q: Is Pipon an opioid or controlled substance?

A: Official information confirms that Pipon is a Non-Steroidal Anti-Inflammatory Drug (NSAID). It is not classified as an opioid and is not listed as a controlled substance in the U.S. regulatory system.


Q: Can Pipon be taken with common pain relievers?

A: Regulatory warnings state that Pipon is generally not recommended for use with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including over-the-counter varieties. Combining these medicines may be associated with an increased potential for serious adverse effects, particularly gastrointestinal events.


Q: Are there any foods or drinks that should be avoided when taking Pipon?

A: Official guidance states that the concurrent use of Pipon with alcohol may increase the risk of severe gastrointestinal issues. Products containing metallic cations, such as certain antacids, must also be separated in time from when the medicine is administered. A high-fat meal is documented to increase the systemic exposure of the drug.


Q: Does Pipon cause weight gain?

A: The medicine is associated with fluid retention or edema. Regulatory documents caution that unusual or rapid weight gain along with swelling can be a warning sign of a serious event like heart failure and is noted in regulatory documents as an event that warrants attention.


Q: How long does the effect of one dose of Pipon last?

A: Pipon has a prolonged half-life, which means it stays in the body for an extended period, approximately 50 hours. This prolonged activity is the reason the medicine is officially dosed just once per day for chronic conditions like rheumatoid arthritis.


Q: Is Pipon safe to use long-term?

A: Official regulatory guidance describes the principle of using the lowest effective dosage for the shortest duration necessary to achieve treatment goals. Long-term use may increase the potential for serious adverse cardiovascular and gastrointestinal events, which are highlighted in regulatory boxed warnings.


Q: Is Pipon available over the counter?

A: Pipon (Piroxicam) is categorized as a prescription-only medicine. It is not available for purchase without a prescription in major regulatory territories.


Q: Is Pipon habit-forming or addictive?

A: Based on its pharmacological class as a Non-Steroidal Anti-Inflammatory Drug (NSAID), Pipon is not associated with being habit-forming or addictive.


Q: Is Pipon safe for elderly people?

A: Official information indicates that older adults are at a greater risk for serious adverse events, particularly those affecting the stomach and intestines. Regulatory guidance specifies that initiating treatment for older adults should be done at the low end of the dosing range.


Q: Can children or teenagers use Pipon?

A: Official regulatory documents state that the safety and effectiveness of Pipon for treating its main indications (Osteoarthritis/Rheumatoid Arthritis) have not been established in children and teenagers.


Q: What are the signs of an allergic reaction to Pipon?

A: Signs of a severe allergic reaction (anaphylaxis) may include difficulty breathing or swelling of the face, lips, throat, or tongue. Severe skin rashes can also occur, which may involve blisters, rash, or peeling skin, according to official patient information.


Q: What should I do if a side effect seems severe?

A: Regulatory guidance outlines that the occurrence of symptoms associated with a serious adverse event, such as chest pain, shortness of breath, slurred speech, or vomiting blood, requires immediate emergency evaluation.


Q: Can Pipon be taken with herbal supplements?

A: The regulatory documents explicitly list the herbal supplement St. John’s Wort as being contraindicated (use is prohibited) with Pipon. Official documentation notes that patients must disclose all medicines and supplements to their prescribing healthcare provider to check for potential drug interactions.


Q: Is there a generic version of Pipon available?

A: Yes, the active ingredient in Pipon, Piroxicam, has been approved by the FDA as a generic version for its capsule dosage form. These generic versions contain the same active ingredient and are approved as equivalent to the branded product.


Q: Can Pipon affect lab test results?

A: The medicine has been associated with reports of abnormal liver function tests in adverse event data. For patients receiving long-term treatment, regulatory documents advise routine monitoring of blood health parameters, such as a complete blood count.


Q: What is the purpose of the black box warning on Pipon's label?

A: The black box warning is the most serious advisory from the FDA. It highlights the risk of serious cardiovascular thrombotic events (like heart attack and stroke) and the risk of serious gastrointestinal bleeding, ulceration, and perforation.


Q: How does the body eliminate or break down Pipon?

A: The active ingredient in Pipon is primarily broken down (metabolized) in the liver. It is then eliminated from the body (excreted) through both the urine and the feces.


Q: Is it common to have headaches when taking Pipon?

A: Yes, headache is listed in the official adverse reactions reported for the medicine. It is considered a common side effect of Pipon, based on the official adverse reactions reported for the medicine.


Q: Can Pipon interact with blood thinners?

A: Yes, official drug interaction information indicates that Pipon can interact with certain blood thinners (anticoagulants). This interaction is associated with an increased risk or severity of bleeding and hemorrhage.


Q: What if Pipon doesn't seem to be working for me?

A: Regulatory documents indicate that assessment of the full therapeutic effect of Pipon may require up to two weeks after starting treatment. This is because the medicine requires time to build up to stable levels in the body.


Q: Does Pipon affect blood pressure?

A: Yes, the official warnings state that the medicine may cause the new onset of high blood pressure or may worsen existing high blood pressure. Official warnings note that blood pressure monitoring during treatment may be necessary.


Q: Is Pipon a newly approved drug or has it been around for a while?

A: Pipon's active ingredient, Piroxicam, has been available for many years. It was initially approved for use by the FDA in 1982, indicating it is an established medicine.

How should Pipon be stored and disposed of?

How to Store and Dispose of Pipon?

The storage and disposal instructions for Pipon (Piroxicam) are governed by official regulatory standards to maintain product stability and ensure public safety.

Required Storage Conditions

Pipon must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from excessive moisture and heat and should not be refrigerated or frozen. To maintain integrity, the medicine must be kept in its original container with the lid tightly closed.

Child-Safety and Disposal

It is a mandatory safety requirement that Pipon be stored out of the sight and reach of children. For disposal, unused or expired medicine should be returned through a medicine take-back program. If a program is unavailable, official guidelines recommend mixing the drug with an undesirable substance (such as dirt) and sealing it before placing it in the household trash. The product must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pipon found in:

A-Z Index: